Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Home-brew morphine: Is opiate production about to get way too easy?

Access to yeast strains modified to produce opiates must be controlled say researchers who warn that stopping criminals using such API manufacturing routes to make narcotics is vital.

US Senator dubs Sovaldi price ‘abuse of power’ and calls to defy patent

US Senator Bernie Sanders has called on the Secretary of Veteran Affairs to invoke a law which would break Gilead’s patent on Hepatitis C drug Sovaldi and allow cheaper generics.

Industry calls for global alignment of qualification and validation guidelines

EFPIA and EGA say European Commission GMP guidance should be more closely aligned with guidelines elsewhere to help international drugmakers understand the recently updated requirements.

Janssen and Rutgers expand R&D as continuous manufacturing picks up steam

Despite pharma being “highly regulated and slow to change,” continuous manufacturing will soon be realised, says Rutgers University which has received an R&D grant from J&J.

EMA: show clinical justification for combination drugs

The EMA has released guidelines on developing combination drugs with more than one active pharmaceutical ingredient (API).

Key Industry Events


Access all events listing

Our events, Shows & Conferences...